Skip to main content

Advertisement

SpringerLink
Log in

Differential Expression and Prognostic Implications of the CCN Family Members WISP-1, WISP-2, and WISP-3 in Human Breast Cancer

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The CCN family has three Wnt-inducted secreted proteins named WISP-1, WISP-2 and WISP-3. These molecules are known to play a diverse role in cells, but their role in cancer cells remains controversial.

Methods

In this study, we analyzed the expression of the three WISP molecules at the mRNA and protein levels in a cohort of 122 human breast tumors and 32 normal breast tissues, and we correlated these findings with patients’ clinical outcomes.

Results

WISP-1 transcripts were found in lower levels in node-positive tumors compared with node-negative tumors (P < .05); were lower in patients with a moderate (P = .01) and poor Nottingham Prognostic Index prognosis (P < .05) compared with good prognostic groups; were of significantly lower level in grade 3 differentiated tumors (P < .05) compared with grade 1; and were of lower levels in patients who developed metastasis and died from breast cancer–related causes (P < .05 in both comparisons). Almost the reverse was found to be true for WISP-2, which had greater levels of expression in node-positive tumors (P = .0043); higher levels in both moderate and poor prognostic groups compared with the good prognostic group (both P < .05); greater level in both grade 2 and 3 when compared with grade 1 (both P < .05); and higher levels in patients who went on to develop metastases (P < .01). WISP-3 transcript levels showed no statistically significant differences between groups.

Conclusions

WISPs may play important but contrasting roles in breast cancer. WISP-1 seems to act as a tumor suppressor and WISP-2 as a factor that stimulates aggressiveness; WISP-3 has no definable beneficial or detrimental role.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.
FIG. 3.
FIG. 4.
FIG. 5.
FIG. 6.
FIG. 7.

Similar content being viewed by others

References

  1. Planque N, Perbal B. A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int 2003; 3:15–30

    Article  PubMed  Google Scholar 

  2. Bringstock D. The CCN family: a new stimulus package. J Endocrinol 2003; 178:169–75

    Article  Google Scholar 

  3. Perbal B, Brigstock D, Lau L. Report on the second international workshop on the CCN family of genes. Mol Pathol 2003; 56:80–5

    Article  PubMed  CAS  Google Scholar 

  4. Leask A, Abraham DJ. All in the CCN family: essential matricellular signalling modulators emerge from the bunker. J Cell Sci 2006; 119:4803–10

    Article  PubMed  CAS  Google Scholar 

  5. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler P. Elevated levels of connective tissue growth factor, WISP-1 and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 2001; 61:8917–23

    PubMed  CAS  Google Scholar 

  6. Pennica D, Swanson T, Welsh J, et al. WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1 transformed cells and aberrantly expressed in human colon tumours. Proc Natl Acad Sci U S A 1998; 95:14717–22

    Article  PubMed  CAS  Google Scholar 

  7. Khor T, Gul Y, Ithnin H, Seow H. A comparative study of the expression of Wnt-1, WISP-1, surviving and cyclin-D1 in colorectal cancer. Int J Colorectal Dis 2006; 21:291–300

    Article  PubMed  Google Scholar 

  8. Soon L, Yie T, Shvarts Levine A, Su F, Tchou-Wong K. Overexpression of WISP-1 down regulated motility and invasion of lung cancer cells through inhibition of rac activation. J Biol Chem 2003; 278:11465–70

    Article  PubMed  CAS  Google Scholar 

  9. Banerjee S, Sengupta K, Saxena N, Dhar K, Banerjee S. Epidermal growth factor induces WISP-2/CCN5 expression in estrogen receptor-α–positive breast tumour calls through multipul modular cross-talks. Mol Cancer Res 2005; 3:151–62

    Article  PubMed  CAS  Google Scholar 

  10. Banerjee S, Saxena N, Sengupta K, Tawfik O, Mayo M, Banerjee S. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia 2003; 5:63–73

    PubMed  CAS  Google Scholar 

  11. Nessling M, Richter K, Schwaenen C, et al. Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. Cancer Res 2005; 65:439–47

    PubMed  CAS  Google Scholar 

  12. Chappell S, Walsh T, Walker RA, Shaw J. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas. Br J Cancer 1997; 76:1558–61

    PubMed  CAS  Google Scholar 

  13. Kleer C, Zhang Q, Lan Q, Merajver S. WISP3 (CCN6) is a gercreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer. Neoplasia 2004; 6:179–85

    Article  PubMed  CAS  Google Scholar 

  14. Zhang Y, Pan Q, Zhong H, Merajver S, Kleer C. Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells. Breast Cancer Res 2005; 7:1080–9

    Article  Google Scholar 

  15. Hanavadi S, Martin T, Mansel R, Jiang W. Interleukin-11 and its receptor expression in human breast cancer. Ann Surg Oncol 2006; 13:802–8

    Article  PubMed  Google Scholar 

  16. Martin T, Goyal A, Mansel R, Watkins G, Jiang W. The transcription factor for the E-cadherin complex, Twist, Slug and Snail, in human breast cancer. Ann Surg Oncol 2005; 12:1–9

    Article  Google Scholar 

  17. Jiang W, Watkins G, Lane J, et al. Prognostic value of Rho family and rho-GDIs in breast cancer. Clin Can Res 2003; 9:6432–40

    CAS  Google Scholar 

  18. Nazarenko A, Bhatnagar S, Hohman R. A closed tube format for amplification and detection of DNA based on energy transfer. Nucleic Acids Res 1997; 25:2516–21

    Article  PubMed  CAS  Google Scholar 

  19. Jiang W, Douglas-Jones A, Mansel R. Level of expression of PPAR-gamma and its co-activator (PPAR-GCA) in human breast cancer. Int J Cancer 2003; 106:752–7

    Article  PubMed  CAS  Google Scholar 

  20. Ye L, Martin T, Parr C, Harrison G, Mansel R, Jiang W. Biphasic effects of 17-β-oestradiol on expression of occluding and transendothelial resistance (TER) and paracellular permiabiliy in human vascular endothelial cells. J Cell Physiol 2003; 196:362–9

    Article  PubMed  CAS  Google Scholar 

  21. King J, Ofori-Acquash A, Stevens T, Al-Mehdi A, Fodstad O, Jiang W. Activated leukocyte adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 2004; 6:478–87

    Article  Google Scholar 

  22. Parr C, Watkins G, Jiang W. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Int J Mol Med 2004; 14:779–86

    PubMed  CAS  Google Scholar 

  23. Jiang W, Grimshaw D, Lane J, et al. A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells. Clin Cancer Res 2001; 7:2555–62. Erratum in: Clin Cancer Res 2002; 8:300

    PubMed  CAS  Google Scholar 

  24. Davies G, Jiang W, Mason M. Cell-cell adhesion and signalling intermediates in human prostate cancer. J Urol 2000; 163:985–92

    Article  PubMed  CAS  Google Scholar 

  25. Jiang WG, Watkins G, Fodstad O, et al. Differential expression of the CCN family members Cyr61 from CTGF and Nov in human breast cancer. Endocr Relat Cancer 2004; 11:781–91

    Article  PubMed  CAS  Google Scholar 

  26. Martin TA, Watkins G, Lane J, Jiang WG. Assessing mircovessels and angiogenesis in human cancer, using VE-cadherin. Histopathology 2005; 46:422–30

    Article  PubMed  CAS  Google Scholar 

  27. Davies G, Rmaili K, Jiang WG. Tumour endothelial marker-8 (TEM-8) in human breast cancer: the correlation with angiogenesis. Int J Oncol 2006; 29:1311–7

    PubMed  CAS  Google Scholar 

  28. Davies G, Mason MD, Mansel RE, Jiang WG. Expression of tumour-endothelial markers in human breast cancer. Clin Exp Metastasis 2004; 21:31–7

    Article  PubMed  CAS  Google Scholar 

  29. Jiang W, Watkins G, Fodsrad O, Douglas-Jones A, Mokbel K, Mansel R. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 2004; 11:781–91

    Article  PubMed  CAS  Google Scholar 

  30. Babic A, Kireeva M, Kolesnikova T, Lau L. CYR61, a product of a growth factor–inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A 1998; 2695:6355–60

    Article  Google Scholar 

  31. Mason H, Lake A, Wubben J, Nowak R, Castellot J Jr. The growth arrest–specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells. Mol Hum Reprod 2004; 10:181–7

    Article  PubMed  CAS  Google Scholar 

  32. Zoubine M, Banerjee S, Saxena N, Campbell D, Banerjee S. WISP-2: a serum-induible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells. Biochem Biophys Res Commun 2001; 282:421–5

    Article  PubMed  CAS  Google Scholar 

  33. Van Golen K, Davies S, Wu Z, et al. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 1999; 5:2511–9

    PubMed  Google Scholar 

  34. Thorstensen L, Diep C, Meling G, et al. WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology 2001; 121:1275–80

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

Supported by Cancer Research Wales.

Author information

Authors and Affiliations

  1. Metastasis and Angiogenesis Research Group, Department of Surgery, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, United Kingdom

    Simon R. Davies MRCS, Gareth Watkins BSc, Robert E. Mansel MS, FRCS & Wen G. Jiang MD

Authors
  1. Simon R. Davies MRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gareth Watkins BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert E. Mansel MS, FRCS
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wen G. Jiang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon R. Davies MRCS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davies, S.R., Watkins, G., Mansel, R.E. et al. Differential Expression and Prognostic Implications of the CCN Family Members WISP-1, WISP-2, and WISP-3 in Human Breast Cancer. Ann Surg Oncol 14, 1909–1918 (2007). https://doi.org/10.1245/s10434-007-9376-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9376-x

Keywords

Search

Navigation